Evidence map›Paper›PMID 23879635›Full record

ArticleNanomedicine (London, England)2014

ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.

Mistuni Ghosh, Robert O Ryan

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Serum Trimethylamine-International journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Reconstituted HDL as a therapeutic delivery device.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mistuni GhoshChildren's Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609, USA.
Robert O Ryan
University of California, Berkeley · US

Funding

Effect of Apolipoprotein Structural AdaptabilityR37HL064159 · NHLBI · UNIVERSITY OF NEVADA RENO · PI RYAN, ROBERT O'MARA · 2010 to 2019
$4.1M
EFFECT OF APOLIPOPROTEIN STRUCTURAL ADAPTABILITYR01HL064159 · NHLBI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI RYAN, ROBERT O'MARA · 2000 to 2009
$3.6M
Pre-doctoral Training in Molecular and Biochemical NutritionT32DK061918 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI NAPOLI, JOSEPH L · 2002 to 2016
$2.6M
NHLBI NIH HHS HL-64159NHLBI NIH HHS R01 HL064159NHLBI NIH HHS R37 HL064159NIDDK NIH HHS T32 DK061918
6 · The paper itself

Abstract

aimTo evaluate the effect of incorporating the polyphenol, curcumin, into nanodisk (ND) particles on its biological activity. MATERIALS &

methodsCurcumin-NDs formulated with different scaffold proteins were incubated with cultured glioblastoma multiforme cells.

resultsWhen ApoE was employed as the ND scaffold protein, enhanced curcumin uptake was observed. Furthermore, ApoE curcumin-NDs induced greater cell death than either free curcumin or ApoAI curcumin-NDs. A total of 1 h after exposure of glioblastoma multiforme cells to ApoE curcumin-NDs, significant curcumin uptake was detected while ApoE was localized at the cell surface. After 2 h, a portion of the curcumin had migrated to the nucleus, giving rise to enhanced fluorescence intensity in discrete intranuclear sites.

conclusionApoE-mediated interaction of curcumin-NDs with glioblastoma multiforme cells leads to enhanced curcumin uptake and increased biological activity.

Indexed as

Antineoplastic AgentsApolipoproteins EApoptosisCell Line, TumorCell SurvivalCurcuminDrug CarriersGlioblastomaHumansNanostructuresAntineoplastic AgentsApolipoproteins ECurcuminDrug CarriersApoEapoptosisconfocal fluorescence microscopycurcuminglioblastomananodisk

Identifiers

PMID23879635
PMCPMC3904962
OpenAlexW2155514466

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.